InvestorsHub Logo

Whitewater55

12/14/19 10:51 PM

#234050 RE: Notademoc #233991

So you are saying that Amarin never plans to make another regulatory submission to the US government (FDA)?

When you get expanded label on a blockbuster, you don’t claim first amendment. It’s sort of like having a legal pot store in California but selling crack out of the back because you aren’t already making oodles of cash.

AnotherInvestor

12/15/19 2:30 AM

#234066 RE: Notademoc #233991

That's a story from 2016. It sounds like AMRN worked out a settlement with the FDA some time ago.

https://www.medpagetoday.com/publichealthpolicy/healthpolicy/56635